Medical News

RSS

Kendle enters into new $35M secured revolving credit facility with JPMorgan Chase Bank N.A.

Kendle, a leading, global full-service clinical research organization, today announced that it has entered into a new $35 million secured revolving credit facility as of March 15, 2010 with JPMorgan Chase Bank N.A., as administrative agent, which replaces the Company's previous revolving credit facility.

18 Mar 2010

Health overhaul supporters, critics duel on airwaves

McClatchy/Miami Herald: "As a historic vote on sweeping healthcare legislation nears, Democratic moderates in the House of Representatives face relentless pressure as they juggle personal pleas from President Barack Obama, a multimillion-dollar ad barrage and constituents who are fed up with the convoluted congressional process.

18 Mar 2010

Novel findings point to new therapeutic approaches for common types of cancer

Increased understanding of the Skp2 gene and its relation to cellular senescence may lead to the development of novel agents that can suppress tumor development in common types of cancer, researchers from The University of Texas M. D. Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center report in the journal Nature.

18 Mar 2010

AMGA to present Medical Group Preeminence Award to HealthTexas Provider Network

The American Medical Group Association announced it will present the Medical Group Preeminence Award on March 20 to HealthTexas Provider Network, an affiliate of Baylor Health Care System based in the Dallas/Fort Worth area of Texas. The presentation will take place at the AMGA 2010 Annual Conference, being held March 18-20 at the New Orleans Marriott.

18 Mar 2010

RainDance Technologies partners with Ambry Genetics to provide sequence enrichment solution for clinical and research studies

Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.

18 Mar 2010

Beneficial impact of vitamin D could alleviate symptoms and treat MS

Glasgow GP Dr Tom Gilhooly is at the forefront of an exciting new treatment for sufferers of MS. He comments ‘Scotland has the greatest incidence of Multiple Sclerosis in the world – and has more to gain than any other country from new developments such as CCSVI.’

18 Mar 2010

Drugmakers are 'under-exposed' in emerging markets, report says

Growing markets for pharmaceuticals in China, Brazil, Russia and India are outpacing national markets in Europe and the U.S., but major drugmakers have been slow to expand in these markets and may lose opportunities, a new study finds, The New York Times reports. To put the shift in perspective, China will overtake both France and Germany next year in terms of drug spending, while Brazil will overtake Britain, according to the report by research firm IMS Health.

18 Mar 2010

Alzheimer's disease: Gene expression level influences promotion of disorder or protection against development

Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in Florida have found that a gene appears to either help protect against development of Alzheimer's disease, or promote the disorder depending on the level of gene in the brain.

18 Mar 2010

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.

18 Mar 2010

Idaho Health Freedom Act does nothing to tackle state's health care crisis, says AARP

The health care crisis hundreds of thousands of Idahoans face every day may have just gone from bad to worse with the stroke of a pen. Today, Governor C.L. "Butch" Otter signed the Idaho Health Freedom Act into law, a bill strongly opposed by AARP.

18 Mar 2010

Taking dietary supplements for adrenal fatigue may do more harm than good

Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.

18 Mar 2010

Esteem hearing system receives FDA approval for treatment of sensorineural hearing loss

The U.S. Food and Drug Administration today announced the approval of the Esteem – an implanted hearing system used to treat moderate to severe sensorineural hearing loss, a type of permanent hearing loss.

18 Mar 2010

Agendia to participate in groundbreaking clinical trial for breast cancer

Agendia, a world leader in molecular cancer diagnostics, announced today it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.

18 Mar 2010

Democrats take aim at deficit targets, continue to wait for CBO numbers on health overhaul

"With Congress just days away from an expected vote, Democrats still hadn't settled on final language of the bill and until they do the Congressional Budget Office can't release an estimate for how much the complete package would cost." House Majority Leader Steny Hoyer (D., Md.) said yesterday that "he hoped Democratic leaders would be able to lock down final details soon.

18 Mar 2010

New findings promise to have fundamental significance in the fight against cancer

Cells have two different protection programs to safeguard them from getting out of control under stress and from dividing without stopping and developing cancer. Until now, researchers assumed that these protective systems were prompted separately from each other.

18 Mar 2010

Dems newly-favored tactic to advance health measure draws GOP rage

The latest strategy House Democratic leaders have considered for passing the health overhaul bill would allow lawmakers to approve a Senate-passed version of the bill without a direct vote, The Washington Post reports. Instead, a so-called "self-executing rule would say that the Senate's version of health-care legislation would be deemed approved if House members adopt a set of changes to that bill."

18 Mar 2010

I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growing breast cancers

The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.

18 Mar 2010

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company’s nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.

18 Mar 2010

Aetna, SBUH announce new agreement for hospital’s participation in Aetna network

Aetna and Stony Brook University Hospital are pleased to announce today a new agreement for the hospital’s participation in the Aetna network. The agreement is effective through April 30, 2011, and will enable Stony Brook physicians currently participating with Aetna to continue their participation uninterrupted.

18 Mar 2010

Cangene receives European Commission approval to market ImmunoGam

Cangene Corporation today reports that it has received European Commission approval to market Cangene's ImmunoGam(TM) (Human Hepatitis B Immunoglobulin), indicated for immunoprophylaxis of hepatitis B.

18 Mar 2010

Medical News

Kendle enters into new $35M secured revolving credit facility with JPMorgan Chase Bank N.A.

Health overhaul supporters, critics duel on airwaves

Novel findings point to new therapeutic approaches for common types of cancer

AMGA to present Medical Group Preeminence Award to HealthTexas Provider Network

RainDance Technologies partners with Ambry Genetics to provide sequence enrichment solution for clinical and research studies

Beneficial impact of vitamin D could alleviate symptoms and treat MS

Drugmakers are 'under-exposed' in emerging markets, report says

Alzheimer's disease: Gene expression level influences promotion of disorder or protection against development

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Idaho Health Freedom Act does nothing to tackle state's health care crisis, says AARP

Taking dietary supplements for adrenal fatigue may do more harm than good

Esteem hearing system receives FDA approval for treatment of sensorineural hearing loss

Agendia to participate in groundbreaking clinical trial for breast cancer

Democrats take aim at deficit targets, continue to wait for CBO numbers on health overhaul

New findings promise to have fundamental significance in the fight against cancer

Dems newly-favored tactic to advance health measure draws GOP rage

I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growing breast cancers

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

Aetna, SBUH announce new agreement for hospital’s participation in Aetna network

Cangene receives European Commission approval to market ImmunoGam

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News